Skip to main content
. 2017 May 8;46(1):26–39. doi: 10.1111/apt.14092

Table 4.

Cohort demographics separated by CD with active inflammation and CD without active inflammation

Crohn's disease with CRP <5 mg/L N=81 Crohn's disease with CRP >5 mg/L N=31 P value Healthy controls N=24 P value
General
Gender n (%) female 32 (39.5%) 10 (32.3%) .478 3 (12.5%) .047
Age at sample years, mean (minimum‐maximum) 41.9 (18‐74) 41.7 (19‐73) .881 41.3 (19‐60) .982
Disease duration at sample years, mean (minimum‐ maximum) 11.9 (0‐35) 10.8 (1‐32) .553 NA NA
Age at diagnosis n (%)
A1, <16 years 9 (11.1%) 3 (9.7%) .881 NA NA
A2, 17‐40 years 57 (70.4%) 21 (67.7%)
A3, >40 years 15 (18.5% 7 (22.6%)
Disease behavior n (%)
Nonstricturing/nonpenetrating 26 (32.1%) 14 (45.2%) .435 NA NA
Stricturing 42 (51.9%) 12 (41.9%)
Penetrating 13 (16.0%) 4 (12.9%)
Disease activity
Clinical disease activity (HBI, % active disease (HBI≥5)) 30 (37.0%) 15 (48.4%) .273 NA NA
Perianal disease n (%) 19 (23.5%) 9 (29.0%) .542 NA NA
Smoking history n (%) NA NA
Current 30 (37.0%) 8 (25.8%) .563 NA NA
Used to smoke 21 (25.9%) 10 (32.3%)
Never 28 (34.6%) 11 (35.5%)
Missing 1 (1.2%) 2 (6.4%)
Medication use n (%)
5‐aminosalycilates 6 (7.4%) 2 (6.5%) .861 NA NA
Corticosteroids 14 (17.3%) 7 (22.6%) .521 NA NA
Immunosuppressants 51 (63.0%) 14 (45.2%) .088 NA NA
Anti‐Tumour Necrosis Factor alpha 27 (33.3%) 9 (29.0%) .663 NA NA
Surgery n (%)
Resection 56 (69.1%) 17 (54.8%) .115 NA NA
Cause of resection
Therapeutic resistance 6 (7.4%) 1 (3.2%) .689 NA NA
Stenosis 35 (43.2%) 11 (35.5%)
Intra‐abdominal fistula/abscess 9 (11.1%) 2 (6.5%)
Stenosis and abscess/fistula 4 (4.9%) 1 (3.2%)
Other 0 (0%) 1 (3.2%)
Missing 1 (1.2%) 1 (3.2%)
Moment of resection
Resection before sample 45 (55.6%) 14 (45.2%) .154 NA NA
Resection after sample 4 (4.9%) 3 (9.7%)
Resection before and after sample 7 (8.6%) 0 (0%)
Re‐resection because of stenosis/intra‐abdominal fistula/abscess 18 (22.2%) 1 (3.2%) .017 NA NA

HBI, Harvey‐Bradshaw Index; NA, not applicable.

Nominal and continuous data were compared using ANOVA. P values depict statistical differences between patients with Crohn's disease and comparing patients with Crohn's disease to controls.